2m 2m 2m 2m 2m 2m 2m
BRGHTSPRNG HLTH (BTSG)
NASDAQ
$66.65-$0.55 (-0.82%)
Price as of Jun 23, 2026 5:05 PM EDT- $13.2BMarket Cap
- 195.13%1-Year Change
- Health Information ServicesIndustry
BRGHTSPRNG HLTH (BTSG)
$66.65-$0.55 (-0.82%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 11.4B +1.59% | 11.3B N/A | |
Cost of Revenue | 885.4M -46.97% | 1.7B N/A | |
Gross Profit | 1.5B -4.45% | 1.6B N/A | |
Sales and Marketing Expense | 1.2B -11.54% | 1.4B N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 164.3M -19.66% | 204.5M N/A | |
Total Operating Expenses | 1.2B -11.54% | 1.4B N/A | |
Operating Profit | 295.3M +43.07% | 206.4M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -157.3M -31.12% | -228.4M N/A | |
Interest Income and Expense and Net | -157.3M -31.12% | -228.4M N/A | |
Total Nonoperating Income and Expense | 157.3M -31.12% | 228.4M N/A | |
Income before Taxes | 137.9M +497.09% | -34.7M N/A | |
Income Taxes | 33.1M +333.14% | -14.2M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | 190.7M +1,155.62% | -18.1M N/A | |
Net Income from Continuing Operations Applicable to Common | 137.9M +497.09% | -34.7M N/A | |
Basic EPS and Net Income | 0.94 +1,144.44% | -0.09 N/A | |
Diluted EPS and Net Income | 0.87 +1,066.67% | -0.09 N/A | |
Basic Weighted Average Shares | 202.6M +4.96% | 193.0M N/A | |
Diluted Weighted Average Shares | 219.8M +13.87% | 193.0M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 88.4M +44.27% | 61.3M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 88.4M +44.27% | 61.3M N/A | |
Total Current Assets | 2.9B +52.88% | 1.9B N/A | |
Accumulated Depreciation | 404.9M -10.09% | 450.3M N/A | |
Property and Plant and Equipment and Net | 204.7M -18.22% | 250.3M N/A | |
Total Long-Term Assets | 39.7M -10.70% | 44.5M N/A | |
Total Assets | 6.4B +8.22% | 5.9B N/A | |
Income Taxes Payable | 6.2M -73.90% | 23.7M N/A | |
Total Short-Term Debt | 52.3M +7.42% | 48.7M N/A | |
Total Current Liabilities | 1.8B +29.45% | 1.4B N/A | |
Total Long-Term Debt | 2.5B -4.16% | 2.6B N/A | |
Total Long-Term Liabilities | 2.6B -6.93% | 2.8B N/A | |
Total Liabilities | 4.5B +5.90% | 4.3B N/A | |
Retained Earnings | -74.6M -66.40% | -222.2M N/A | |
Total Stockholders Equity | 1.9B +13.79% | 1.6B N/A | |
Total Shares Outstanding | 192.1M +10.26% | 174.2M N/A | |
Cash Flow | |||
Cash from Operating Activities | 490.2M +1,961.79% | 23.8M N/A | |
Capital Expenditures | 95.5M +18.01% | 80.9M N/A | |
Cash from Investing Activities | -305.1M +117.55% | -140.2M N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | -157.9M -195.88% | 164.6M N/A | |
Financials Ratio | |||
Gross Margin | 92.26% N/A | N/A N/A | |
Operating Margin | 2.58% N/A | N/A N/A | |
Return on Assets | 3.09% N/A | N/A N/A | |
Return on Equity | 10.82% N/A | N/A N/A | |
Revenue Growth | 1.59% N/A | N/A N/A | |
Current Ratio | 1.57 N/A | N/A N/A | |
Cash Ratio | 0.05 N/A | N/A N/A | |
Debt-to-Equity Ratio | 1.34 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.39 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow